Skip to main content Skip to footer


Professional Summary

Clifford Brechner joined Colliers in 2019 to focus his talents in the fast-growing Philadelphia Life Sciences division. 

Clifford comes to Colliers with more than 35 years of experience leading companies with revenues in excess of $10 million. For the past 20 years Brechner has led ventures within the analytical laboratory and quality assurance industry, making him exceptionally suited to help laboratory clients navigate their complicated real estate needs in an ever-changing market. 

Clifford is a native of New York and currently resides in Bryn Mawr with his wife and two children. 



As Founder and CEO of Insight Laboratories, a consumer products safety testing lab, Clifford built and managed facilities in Singapore, Hong Kong, Shanghai, Canada and California, New York, Connecticut, and Pennsylvania.  With rapid growth and ISO17025 and Consumer Product Safety Commission approval, Insight was acquired by a strategic partner. 

As Co-Founder and CEO of Actus Analytical, Clifford also managed the development, marketing and sales of instruments for consumer safety compliance screening. Under Clifford’s leadership, Actus Analytical was awarded a research grant from U.S. Department of Homeland Security and the CPSC, and partnered with Agilent Technologies to develop a portable analytical instrument for the screening of material ID.

Memberships & Involvements

Licensed Real Estate Salesperson in Pennsylvania


Service Lines

Landlord Representation, Tenant Representation, Occupier Services

Property Type



Life Sciences Group

My Team

Featured Research

Mar 21, 2022

Philadelphia Will Be a Leading City for Life Sciences Biomanufacturing

From Colliers Life Sciences Philadelphia, learn about the seven factors driving Philadelphia’s emergence as a leading biomanufacturing city.
Read More
Nov 17, 2021

Breaking Through | Philadelphia Life Sciences 2021 Market Report

In Colliers Life Sciences' newest report for the Philadelphia market, exciting dynamics are aligning that together have the ability to push Philadelphia ahead from a top tier market to an elite U.S. biocluster.
Read More
Nov 23, 2020

Converging for Cures | Philadelphia Life Sciences 2020 Market Report

Learn how Philadelphia is coming together as a Life Sciences ecosystem with the emergence of clear “neighborhoods” - each with a flight path for continued development and expansion.
Read More
View More

Featured News

May 19, 2022

PIDC and Colliers Announce Landmark Life Sciences Development Opportunity in Philadelphia

Lower Schuylkill Biotech Campus solicitation offers opportunity for development of up to 1M square feet in an elite US bio cluster
Read More
Jul 26, 2021

Pioneering Past Informs Future as Budd Bioworks Takes Shape

After Decades of Dormancy, Philadelphia’s Powerhouse Budd Plant Presses Ahead as a New Biomanufacturing Center
Read More
View More

How can I help you?

* Required Field